Upregulation of Pluripotency Markers in Adipose Tissue-Derived Stem Cells by miR-302 and Leukemia Inhibitory Factor
Figure 6
(a) The pEGFPC1-miR-302 vector, (b and c) expression of EGFP in the third-passaged ADSCs, 24 h after transfection with pEGFP-C1-miR-302 using Lipofectamine 2000.
